MET-MED Trial: A phase III randomised double-blind placebo-controlled trial of metformin for cognitive recovery and white matter growth in paediatric medulloblastoma patients

  • Hansford, Jordan (Primary Chief Investigator (PCI))
  • de Luca, Cinzia Rachele (Chief Investigator (CI))
  • Mabbott, Donald James (Chief Investigator (CI))
  • Bouffet, Eric (Chief Investigator (CI))
  • Carr, Michelle (Chief Investigator (CI))
  • Jones, Janelle (Chief Investigator (CI))
  • Wood, Paul (Chief Investigator (CI))
  • Strong, Robyn (Project Manager)
  • May, Kylie (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date1/06/20 → 31/05/26

Keywords

  • medulloblastoma
  • cognitive function
  • paediatric
  • stem cell biology
  • survivorship

Clinical Trial Phase

  • Phase III (a & b)
  • External Sponsor